Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
BetterLife Announces Closing of a Private Placement for BETR-001 and BETR-002 Compounds
Jul 02, 2024
Contract Type
partnership
VancouverBiotechnology
Description
BetterLife Pharma Inc. announced the closing of a non-brokered private placement, pursuant to which the Company issued 1,750,000 units at a price of $0.10 per Unit for aggregate gross proceeds of $175,000. The company primarily focuses on developing and commercializing BETR-001 and BETR-002 compounds to treat neuro-psychiatric and neurological disorders.
Company Information
Company
BetterLife Pharma
Location
Vancouver, British Columbia, Canada
About
BetterLife Pharma Inc. is an emerging biotechnology company primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders.
VancouverBiotechnology